0.4430
+0.0130
+(3.02%)
At close: April 15 at 4:00:00 PM EDT
Breakdown
TTM
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Operating Cash Flow
-2,029.9940
-2,080.6600
-1,966.4530
-2,128.8280
-1,710.2120
Investing Cash Flow
-19.3520
-30.9590
-28.6490
-4.5920
-121.8110
Financing Cash Flow
-170.6120
-143.5270
10.8820
492.5000
3,490
End Cash Position
2,801.9990
4,214.7910
6,469.9370
8,454.1570
10,095.0770
Capital Expenditure
-17.5420
-29.1490
-28.6490
-4.5920
-75.8110
Issuance of Capital Stock
--
--
135
492.5000
3,490
Repayment of Debt
-170.6120
-143.5270
-124.1180
--
--
Free Cash Flow
-2,047.5360
-2,109.8090
-1,995.1020
-2,133.4200
-1,786.0230
4/30/2021 - 8/27/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NURO NeuroMetrix, Inc.
4.3800
+1.15%
ARAY Accuray Incorporated
1.5000
-0.66%
FORZ Forza Innovations Inc.
0.0001
0.00%
PMEDF Predictmedix AI Inc.
0.0210
0.00%
SRDX Surmodics, Inc.
28.34
-0.35%
POSC Positron Corporation
1.6000
-3.61%
PMED.CN Predictmedix AI Inc.
0.0300
-14.29%
AXDX Accelerate Diagnostics, Inc.
0.5400
-1.10%
SERA Sera Prognostics, Inc.
3.3000
-1.20%
TLTFF Theralase Technologies Inc.
0.1500
0.00%